Deprescribing antidepressants: An integral and neglected component of high-quality prescribing practice

No Thumbnail Available

Authors

Horowitz, Mark
Taylor, David

Issue Date

01/06/2025

Type

Journal article

Language

Keywords

Mental Health

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

The Editorial by Looi and colleagues provided a one-sided view of the need to consider deprescribing antidepressants in Australia. They overlooked clear evidence that at least a third of patients no longer meet criteria for ongoing use of antidepressants – this would mean a million people in Australia. They minimised the harms of antidepressants and over-emphasised their benefits in the long term. In addition to this, the authors mis-characterised the Maudsley Deprescribing Guidelines as advocating deprescribing antidepressants even when patients do not wish to stop them or when there is clear benefit. The aim of the Maudsley Deprescribing Guidelines is to give advice on how to stop antidepressants safely in situations where it is in a patient’s best interest. Introduction We wish to reply to the editorial by Looi et al.1 We are glad that the authors agree that hyperbolic tapering is the most sensible approach to deprescribing antidepressants. However, they minimise evidence of overprescribing and misrepresent aspects of the Maudsley Deprescribing Guidelines.2 The editorial erroneously characterises the Maudsley Deprescribing Guidelines as advocating ‘population-level deprescribing of antidepressants’, – deprescribing even when against the wishes of the patient (as in cases where ‘patients maintain a preference for medication’) or where patients ‘are benefiting’. In fact, the book offers guidance on how to stop antidepressants in a safe manner when this is in the best interests of the patient and when they agree to the process through shared decision-making. It does not advocate deprescribing for those benefiting from medication or those who wish to continue it.

Description

Citation

Australasian Psychiatry. 2024;33(3):329-332. doi:10.1177/10398562241308437

Publisher

License

Journal

Australasian Psychiatry

Volume

33

Issue

3

PubMed ID

DOI

ISSN

EISSN

Collections